Elevated M2-muscarinic and β1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation

Clinical Research in Cardiology

Volumn 104, Issue 3, 2015, Pages 226-233

  Yalcin, Muhammed U ^a   Gurses, Kadri M ^a   Kocyigit, Duygu ^a   Kesikli, Sacit Altug ^b   Ates, Ahmet Hakan ^a   Evranos, Banu ^a   Yorgun, Hikmet ^a   Sahiner, Mehmet L ^a   Kaya, Ergun B ^a   Oto, Mehmet A ^a   Guc, Dicle ^b   Ozer, Necla ^a   Aytemir, Kudret ^a  

^a Department of Cardiology ^*  (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Anti M2 muscarinic receptor autoantibody; Anti 1 adrenergic receptor autoantibody; Cardiac autoantibodies; Lone atrial fibrillation

Indexed keywords

AUTOANTIBODY; BETA 1 ADRENERGIC RECEPTOR; MUSCARINIC M2 RECEPTOR; ADRB1 PROTEIN, HUMAN; BIOLOGICAL MARKER; CHRM2 PROTEIN, HUMAN;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PARASYMPATHETIC TONE; SENSITIVITY AND SPECIFICITY; ATRIAL FIBRILLATION; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTOR; STATISTICAL MODEL; TURKEY; UPREGULATION;

ATRIAL FIBRILLATION; AUTOANTIBODIES; BIOMARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RECEPTOR, MUSCARINIC M2; RECEPTORS, ADRENERGIC, BETA-1; RISK FACTORS; TURKEY; UP-REGULATION;

EID: 84923832449     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0776-1     Document Type: Article

References (22)

1. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P, Guidelines-CPG ESCCfP, Document R (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association. Europace 14(10):1385–1413. doi:10.1093/europace/eus305
2. Linz D, van Hunnik A, Ukena C, Ewen S, Mahfoud F, Schirmer SH, Lenski M, Neuberger HR, Schotten U, Bohm M (2014) Renal denervation: effects on atrial electrophysiology and arrhythmias. Clin Res Cardiol: Off J Ger Card Soc. doi:10.1007/s00392-014-0695-1
3. Zhang M, Tao H, Shi KH (2014) Renal denervation as a friend of catheter ablation in patients with atrial fibrillation and hypertension. Clin Res Cardiol: Off J Ger Card Soc. doi:10.1007/s00392-014-0752-9
4. Greif M, von Ziegler F, Wakili R, Tittus J, Becker C, Helbig S, Laubender RP, Schwarz W, D’Anastasi M, Schenzle J, Leber AW, Becker A (2013) Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation. Clin Res Cardiol: Off J Ger Card Soc 102(8):555–562. doi:10.1007/s00392-013-0566-1
5. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS, Smith SC Jr, Priori SG, Estes NA 3rd, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Jacobs AK, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson WG, Tarkington LG, Yancy CW, American College of Cardiology Foundation, American Heart Association Task F (2011) 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 123(10):e269–e367. doi:10.1161/CIR.0b013e318214876d
6. Wyse DG, Van Gelder IC, Ellinor PT, Go AS, Kalman JM, Narayan SM, Nattel S, Schotten U, Rienstra M (2014) Lone atrial fibrillation: does it exist? J Am Coll Cardiol 63(17):1715–1723. doi:10.1016/j.jacc.2014.01.023
7. Kallwellis-Opara A, Dorner A, Poller WC, Noutsias M, Kuhl U, Schultheiss HP, Pauschinger M (2007) Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol: Off J Ger Card Soc 96(7):469–480. doi:10.1007/s00392-007-0524-x
8. Baba A, Fu M (2008) Autoantibodies in atrial fibrillation: actor, biomaker or bystander? Autoimmunity 41(6):470–472. doi:10.1080/08916930802031504
9. Maixent JM, Paganelli F, Scaglione J, Levy S (1998) Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 9(6):612–617
10. Zou C, Zhang Z, Zhao W, Li G, Ma G, Yang X, Zhang J, Zhang L (2013) Predictive value of pre-procedural autoantibodies against M2-muscarinic acetylcholine receptor for recurrence of atrial fibrillation one year after radiofrequency catheter ablation. J Transl Med 11:7. doi:10.1186/1479-5876-11-7
11. Novikova DS, Bekbosynova MS, Antidze T, Loladze NV, Domogatskii SP, Golitsyn SP, Nasonov EL, Denisova IA, Tonevitskii SP (2004) Autoantibodies against beta(1)-adrenoreceptors in patients with cardiac rhythm disorders. prevalence and possible role in development of arrhythmia. Kardiologiia 44(7):17–22
12. Mandal K, Jahangiri M, Mukhin M, Poloniecki J, Camm AJ, Xu Q (2004) Association of anti-heat shock protein 65 antibodies with development of postoperative atrial fibrillation. Circulation 110(17):2588–2590. doi:10.1161/01.CIR.0000136825.96029.A5
13. Baba A, Yoshikawa T, Fukuda Y, Sugiyama T, Shimada M, Akaishi M, Tsuchimoto K, Ogawa S, Fu M (2004) Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 25(13):1108–1115. doi:10.1016/j.ehj.2004.05.012
14. Stavrakis S, Yu X, Patterson E, Huang S, Hamlett SR, Chalmers L, Pappy R, Cunningham MW, Morshed SA, Davies TF, Lazzara R, Kem DC (2009) Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves’ hyperthyroidism. J Am Coll Cardiol 54(14):1309–1316. doi:10.1016/j.jacc.2009.07.015
15. Chiale PA, Ferrari I, Mahler E, Vallazza MA, Elizari MV, Rosenbaum MB, Levin MJ (2001) Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 103(13):1765–1771
16. Brisinda D, Sorbo AR, Venuti A, Ruggieri MP, Manna R, Fenici P, Wallukat G, Hoebeke J, Frustaci A, Fenici R (2012) Anti-beta-adrenoceptors autoimmunity causing ‘idiopathic’ arrhythmias and cardiomyopathy. Circ J: Off J Jpn Circ Soc 76(6):1345–1353
17. Kurt M, Tanboga IH, Karakas MF, Buyukkaya E, Akcay AB, Sen N, Bilen E (2012) The relationship between atrial electromechanical delay and P-wave dispersion with the presence and severity of metabolic syndrome. Turk Kardiyoloji Dernegi arsivi: Turk Kardiyoloji Derneginin yayin organidir 40(8):663–670. doi:10.5543/tkda.2012.97404
18. Hong CM, Zheng QS, Liu XT, Shang FJ, Wang HT, Jiang WR (2009) Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo. Cardiology 112(3):180–187. doi:10.1159/000149152
19. Chiale PA, Garro HA, Schmidberg J, Sanchez RA, Acunzo RS, Lago M, Levy G, Levin M (2006) Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta andrenergic receptors. Heart rhythm: Off J Heart Rhythm Soc 3(10):1182–1186. doi:10.1016/j.hrthm.2006.06.011
20. Chiale PA, Rosenbaum MB, Elizari MV, Hjalmarson A, Magnusson Y, Wallukat G, Hoebeke J (1995) High prevalence of antibodies against beta 1- and beta 2-adrenoceptors in patients with primary electrical cardiac abnormalities. J Am Coll Cardiol 26(4):864–869. doi:10.1016/0735-1097(95)00262-2
21. Christ T, Wettwer E, Dobrev D, Adolph E, Knaut M, Wallukat G, Ravens U (2001) Autoantibodies against the beta 1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol 33(8):1515–1525. doi:10.1006/jmcc.2001.1414
22. Molina CE, Leroy J, Richter W, Xie M, Scheitrum C, Lee IO, Maack C, Rucker-Martin C, Donzeau-Gouge P, Verde I, Llach A, Hove-Madsen L, Conti M, Vandecasteele G, Fischmeister R (2012) Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias. J Am Coll Cardiol 59(24):2182–2190. doi:10.1016/j.jacc.2012.01.060